glp-1 agonist hair loss Glucagon-like peptide-1 receptor agonists (GLP-1RAs) have become increasingly popular for the management of obesity and diabetes. You know these drugs by names like semaglutide (Ozempic, Wegovy), tirzepatide (Mounjaro, Zepbound), and liraglutide (Saxenda GLP-1s May Cause Hair Thinning

Glucagon promotes satiety and increases energy expenditure in humans

37 CONCLUSION In consideration of clinical trials published thus far, oral semaglutide has demonstrated efficacy in terms of A1C and weight reduction when used as an addon to a variety of background glucose-lowering regimens in patients with T2DM and inadequate glycemic control

However, adding GIP agonism significantly enhances results, suggesting GIP contributes meaningfully to overall weight loss through metabolic effects beyond pure appetite control

Saxenda is not for treating type 1 or type 2 diabetes and is not is not a weight-loss medicine or appetite suppressant (Drugs.com)

Furthermore, developing new treatments is anticipated to fuel the growth of the GLP-1 receptor agonist market